Viking Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, Aug. 28, 2018 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in three upcoming investor conferences.
B. Riley FBR Annual Healthcare Investor Conference
The company will attend and participate in 1-on-1 meetings at the B. Riley FBR Annual Healthcare Investor Conference, which is being held in New York on September 4, 2018. The conference will take place at the New York Marriott East Side.
H.C. Wainwright 20th Annual Global Investment Conference
Chief executive officer, Brian Lian, Ph.D., will present a corporate overview at the H.C. Wainwright 20th Annual Global Investment Conference, which is being held in New York on September 4-6, 2018.
Details of the presentation are as follows:
Time/Date: Wednesday, Sept. 5 at 10:00 - 10:25 AM ET (webcast available) Location: The St. Regis, New York Room: Louis XVI A (2nd Floor)
Citi's 13th Annual Biotech Conference
The company will attend and participate in 1-on-1 meetings at Citi's 13th Annual Biotech Conference, which is being held in Boston on September 5-6, 2018. The conference will take place at the Four Seasons Hotel.
To access the live webcast of the H.C. Wainwright presentation, please visit "Webcasts & Presentations" within the News & Events section of Viking's Investors page at www.vikingtherapeutics.com. Additionally, a replay of the webcast will be available on the Viking website following the conference.
About Viking Therapeutics, Inc.
Follow Viking on Twitter @Viking_VKTX.
SOURCE Viking Therapeutics, Inc.
Company Codes: NASDAQ-SMALL:VKTX